Facts

Numbers are powerful and can be persuasive pieces of evidence. However each person’s unique and individual response to multiple myeloma is a greater factor. Myeloma statistics provide general information without individual detail. Current statistics may underestimate improved treatment outcomes of newer agents, drug combinations and better supportive care.

Once considered a disease of the elderly 70+ years old, myeloma is being found in younger people. Whether this is due to greater awareness, or increasing numbers, the average age now is the early 60s, with a few people being diagnosed in their late twenties, thirties and forties.

Multiple Myeloma in Canada

In Canada there are about 6645 people living with multiple myeloma.

Total Male Female
2011 Estimated New Cases 2,300 1,300 1000
2011 Estimated Deaths 1,350 730 640

Estimated new cases by Sex and Province in Canada in 2009:

Canada NL PE NS NB QC ON MB SK AB BC
Males 1300 15 10 40 30 350 510 40 35 110 150
Females 1000 10 5 30 25 270 420 30 25 90 110
Totals 2300 25 15 70 55 620 930 70 60 200 260

Multiple Myeloma in British Columbia

Estimated Number of Multiple Myeloma Cases Diagnosed in 2011
Age at Diagnosis and Gender
0-19 20-39 40-59 60-79 80+ Total 276
M F M F M F M F M F M F
0 0 1 1 30 20 90 62 36 35 157 119

In 2013, estimated new cancer diagnoses are reported to be 167 men and 126 women, for a total of 294.

Myeloma Cancer Deaths in BC for 2009
Age at Diagnosis and Gender
0-19 20-39 40-59 60-79 80+ Total 142
M F M F M F M F M F M F
0 0 1 0 9 7 48 27 27 23 85 57

Regional Stats (BC)

Provincial Health Authority Regions Cancer Diagnosis Cancer Deaths
Interior 54 29
Fraser 78 50
Vancouver Coastal 60 31
Vancouver Island 51 39
Northern 19 11

The Regional myeloma statistics include both men and women living in each of the five health authority regions in a given year.

Most of the persons dying from cancer in a given year were diagnosed in previous years. Fraser region has the largest number of new cases and deaths because it has the largest population.

Canadians Living Longer

The Medical Post reported on a study of 461 myeloma patients in BC where Dr. C. Venner, a haematologist with the Leukemia/ Bone Marrow Transplant Program of British Columbia, explained an increase in lifespan for those in Canada living with multiple myeloma. The findings showed the new drugs, lenalidomide (Revlimid) and bortezomib (Velcade) work and prolong survival in both high – and low risk cases. “The novel agents gave patients – who without the drugs, would have a poor prognosis – at least as good an outcome as low-risk patients with a good prognosis used to have pre – 2004,” said Dr. Venner.